Inventor

Gabor Butora

Inventor
Martinsville, NJ, US

Overview

23→
Patents
1999–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07HSugars12%
C12NMicroorganisms or enzymes12%
A61KPreparations for medical, dental or toiletry purposes10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07KPeptides3%
C07CAcyclic or carbocyclic compounds1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
10,653,712High purity RNA compositions and methods for preparation thereof202010,570,388Phosphate replacement MRNA cap analogs202010,563,195Phosphate replacement mRNA cap analogs202010,428,106Phosphate replacement mRNA cap analogs201910,286,086Alternative nucleic acid molecules and uses thereof20199,884,886'Disulfide masked prodrug compositions and methods'20189,732,111'2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases'20179,624,249'Nucleoside kinase bypass compositions and methods'20179,512,426'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20168,877,439'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20147,632,821'Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection'20097,598,243'Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity'20097,589,085'Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity'20097,534,767'C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase'20097,390,803'Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity'20087,247,725'Gamma-aminoamide modulators of chemokine receptor activity'20077,230,008'Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity'20077,166,614'Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity'20076,812,234'Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity'20046,545,023'Cyclopentyl modulators of chemokine receptor activity'20036,242,604'Process for preparing a morphinan derivative'20016,136,979'Process for preparing a morphinan derivative'20005,912,347'Process for preparing a morphinan derivative'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2001Patents assigned to MALLINCKRODT INC (3)· patent assignee history
1999–2001Based in Gainesville, FL, US· patent location history
2003–2009Patents assigned to MERCK & CO INC (9)· patent assignee history
2003–2020Based in Martinsville, NJ, US· patent location history
2004–2018Patents assigned to MERCK SHARP & DOHME (5)· patent assignee history
2014–2016Patents assigned to SIRNA THERAPEUTICS INC (2)· patent assignee history
2016Based in Rahway, NJ, US· patent location history
2019–2020Patents assigned to MODERNATX INC (5)· patent assignee history
2019Based in Cambridge, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK & CO INC92003–2009
MERCK SHARP & DOHME52004–2018
MODERNATX INC52019–2020
MALLINCKRODT INC31999–2001
SIRNA THERAPEUTICS INC22014–2016
Locations
LocationPatentsSpan
Martinsville, New Jersey, US182003–2020
Gainesville, Florida, US31999–2001
Cambridge, Massachusetts, US12019
Rahway, New Jersey, US12016